← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Cenna Biosciences, Inc.
La Jolla, CA
$12,092,486
Total funding
5
Grants
Funding over time
peak $1.8M · FY2012–25$2M$1.5M$1M$500K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$12,092,486 · 5
By mechanism
R44$11,605,707 · 3
R43$486,779 · 2
Investigators at Cenna Biosciences, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Not enough data
Largest grants
IND-Enabling Pre-clinical Development of Modified P8 for the Treatment of Alzheimer's Disease$1,750,000
R44 · FY2020 · AG
EARLY CLINICAL DEVELOPMENT OF MODIFIED P8 FOR THE TREATMENT OF ALZHEIMER'S DISEASE$1,633,354
R44 · FY2025 · AG
IND-Enabling Pre-clinical Development of Modified P8 for the Treatment of Alzheimer's Disease$1,610,358
R44 · FY2021 · AG
EARLY CLINICAL DEVELOPMENT OF MODIFIED P8 FOR THE TREATMENT OF ALZHEIMER'S DISEASE$1,041,646
R44 · FY2024 · AG
Small molecule therapeutics for Alzheimer's Disease$999,998
R44 · FY2018 · AG
Small molecule therapeutics for Alzheimer's Disease$999,998
R44 · FY2019 · AG
Progressing the Pre-clinical development of P8 for Alzheimer's Disease$750,000
R44 · FY2017 · AG
Intranasal Delivery of Peptide Drugs to the Brain$750,000
R44 · FY2015 · AG
Progressing the Pre-clinical development of P8 for Alzheimer's Disease$747,850
R44 · FY2018 · AG
Intranasal Delivery of Peptide Drugs to the Brain$746,899
R44 · FY2016 · AG
Small molecule therapeutics for Alzheimer's Disease$374,500
R44 · FY2019 · AG
Intranasal Delivery of Peptide Drugs to the Brain$261,779
R43 · FY2012 · AG
Small molecule therapeutics for Alzheimer's Disease$225,000
R43 · FY2016 · AG
IND-Enabling Pre-clinical Development of Modified P8 for the Treatment of Alzheimer's Disease$101,144
R44 · FY2021 · AG
Intranasal Delivery of Peptide Drugs to the Brain$99,960
R44 · FY2017 · AG